GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

Tissue Repair TRP.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

0.14

—

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in AUD, from our data supplier.

FY2026

Revenue

A$559,702

FY2019FY2026

Net income

−A$5.4m

FY2019FY2026

Free cash flow

−A$7.5m

FY2019FY2026

Shareholders' equity

A$8.8m

FY2019FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
RevenueA$559,702A$2.6mA$152,240A$3,076A$171,921A$152,636A$156—
Gross profit−A$1.8mA$2.6mA$150,511A$428A$170,208A$152,636A$156—
Research and developmentA$4.9mA$4.0mA$3.2mA$2.6mA$1.4mA$354,138A$325,075—
Operating income−A$8.0m−A$4.7m−A$6.5m−A$5.7m−A$4.2m−A$639,700−A$448,720−A$557,220
Net income−A$5.4m−A$4.2m−A$4.1m−A$4.2m−A$6.8m−A$915,227−A$352,214−A$357,190
Diluted earnings per share-0.09-0.07-0.07-0.07-0.11-0.02-0.01-0.01

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Total assetsA$10.3mA$14.6mA$19.4mA$22.4mA$25.9mA$27.6mA$1.3mA$810,000
Cash and short-term investmentsA$4.8mA$12.3mA$16.4mA$21.4mA$25.5mA$27.1mA$1.1mA$600,000
Total liabilitiesA$1.6mA$662,535A$1.4mA$497,347A$559,645A$536,000A$329,112A$680,000
Debt—————A$7.5m——
Shareholders' equityA$8.8mA$13.9mA$18.0mA$21.9mA$25.3mA$27.1mA$999,904A$130,000
Shares outstanding60m60m60m60m60m60m33m41m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations−A$7.5m−A$3.7m−A$5.0m−A$4.3m−A$4.0m−A$852,891−A$649,984−A$60,000
Capital spending−A$43,641−A$421,669−A$3,355−A$2,244−A$3,924−A$3,924−A$3,924—
Free cash flow−A$7.5m−A$4.1m−A$5.0m−A$4.3m−A$4.0m−A$856,815−A$653,908−A$60,000

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Mar 2024Dec 2023Sept 2023
RevenueA$253,882A$305,820A$2.0mA$654,319A$1.7mA$866,137A$58,586A$29,293
Gross profit−A$967,511—A$2.0mA$654,319A$1.7mA$863,528−A$858,366A$26,684
Operating income−A$4.6m−A$3.4m−A$1.5m−A$3.2m−A$2.4m−A$1.2m−A$2.5m−A$1.3m
Net income−A$3.2m−A$2.2m−A$1.7m−A$2.6m−A$1.9m−A$940,545−A$2.3m−A$1.1m
Diluted earnings per share-0.05-0.04-0.03-0.04-0.03-0.02-0.04-0.02
Cash from operations—−A$4.0m−A$1.0m−A$2.0m−A$2.0m−A$1.0m−A$2.0m−A$1.0m
Total assetsA$10.3mA$12.4mA$14.6mA$16.7mA$19.4mA$19.4mA$20.6mA$20.6m
Cash and short-term investmentsA$4.8mA$8.3mA$12.3mA$14.4mA$16.4mA$16.4mA$19.3mA$19.3m
Shareholders' equityA$8.8mA$11.8mA$13.9mA$15.6mA$18.0mA$18.0mA$19.8mA$19.8m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue466.7%29.7%—
Operating income11.6%65.6%—
Net income8.7%42.4%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin26.0%29.3%35.5%—
Operating margin-397.7%-745.3%-811.9%—
Net margin-300.7%-535.0%-698.8%—

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021
Price to earnings-1.5-5.5-4.1-3.2-2.0-36.0
Price to sales14.08.8111.1—80.9215.9

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.